These results imply that patients with low SNRPE expression show an enhanced response to ICIs, likely due to the inhibition of TME components that support tumor progression, including the NOTCH1 signaling cascade, tumor necrosis factor (TGFB), and VEGF pathways. Here, TGFB1 is linked to neoplasm.